Jardel Massari new CEO of Ourofino
Ourofino anuncia Jardel Massari como novo Diretor Presidente
Intel ID : 242451
| Synopsis |
|
Ourofino (BVMF: OFSA3), a São Paulo-based veterinary pharmaceuticals company, announced Jardel Massari as the new CEO, according to the company in Comunicado published on 10 November, 2016. Jardel Massari will replace Dolivar Coraucci who recently resigned.
(content in portuguese)
A Ourofino (BVMF:OFSA3), empresa com sede em São Paulo que se dedica à fabricação e distribuição produtos farmacêuticos veterinários, anunciou Jardel Massari como novo Diretor Presidente, segundo publicou a empresa em Comunicado no dia 10 de novembro de 2016. De acordo com o comunicado, Jardel Massari vai substituir à Dolivar Coraucci que renunciou o cargo recentemente. |
Relevant Documents
| Notice / Relevant Fact | 10 Nov 2016 | Ourofino_Comunicado_2016.pdf | PT |
|
| Intel ID | 242451 | |
| Value | ND | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Ourofino
(31 Dec 2024) |
Revenue: EUR 159,98m EBITDA: EUR 35,05m Net Debt: EUR 19,58m Exchange Rate: 
|
|
| Date |
|
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
15.09.02 Pet Food & Pet Supplies Manufacturing 15 Consumer Products & Services / 15.09 Pet Products & Services |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.